The correlation results in our study suggested that more metabolically active regions within the recurrent tumour lesion tend to express higher levels of PSMA, as they have increased neoangiogenesis, which reflects what has previously been observed in treatment naïve high-grade glioma patients [17]. This evidence concerns the gene FOLH1 and neoplasm.